Osmind, Inc.
Healthcare Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
444 De Haro St Ste 210, San Francisco, C...Phone Number
(650) 800-5440Website
www.osmind.orgRevenue
$14.7 MillionIndustry
About Osmind, Inc.
Osmind, Inc. Org Chart
Is Osmind, Inc. your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Osmind, Inc., which may be a good buyer, showed buying intent in Masked Content Topic
Check if Osmind, Inc. has recently received funding, and reach out quickly before it becomes old news!
Click to see if Osmind, Inc. had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Osmind, Inc.
Product Launch: Get notified when Osmind, Inc. launches new products
Funding: Get notified immidiatlly once Osmind, Inc. has new funding data
Check out if Osmind, Inc. is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Osmind, Inc. recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Osmind, Inc.
Compare insights from companies similar to Osmind, Inc., focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Osmind, Inc. is experiencing very low activity levels compared to other companies in the Healthcare Services sector.
What does this means?
Osmind, Inc. is drawing exceptional interest within the Healthcare Services industry, suggesting notable developments or strong market momentum, learn more about Osmind, Inc..
Osmind, Inc. financials insights
Gather financial insights about Osmind, Inc., including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Angel/Seed
$2M
Series A
$15M
Series B
$40M
Osmind, Inc. Tech Stack
A closer look at the technologies used by Osmind, Inc.
Most Recent Scoops
Osmind, Inc. News & Media
Osmind Appoints Dr. William Sauvé as Chief Medical Officer to Advance Interventional Psychiatric Care
SAN FRANCISCO--(BUSINESS WIRE)--Osmind Appoints Dr. William Sauvé as Chief Medical Officer to Advance Interventional Psychiatric Care and Drive Network Growth.UBC ANNOUNCES PARTNERSHIP WITH OSMIND TO ADVANCE THE FUTURE OF MENTAL HEALTH TREATMENT AND RESEARCH WITHIN REMS
First-of-its-kind partnership in mental health care reduces REMS implementation burden, improves the quality of REMS data, and optimizes safe medication use and health outcomes KING OF PRUSSIA, Pa., Oct. 29, 2024 /PRNewswire/ -- United BioSource LLC (UBC), a leading provider of evidence...Osmind Increases Access to Breakthrough Mental Health Treatments through Partnerships with Enthea and First Tracks Health
SAN FRANCISCO--(BUSINESS WIRE)--Osmind Increases Access to Breakthrough Mental Health Treatments through Partnerships with Enthea and First Tracks Health.Osmind Announces Collaboration with the American Psychiatric Association to Advance Quality Psychiatric Care and Accelerate Research
SAN FRANCISCO--(BUSINESS WIRE)--Osmind announced an innovative collaboration with the APA to improve the adoption of measurement-based care and precision treatment in psychiatry.
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Osmind, Inc.
Founded in 2020, Osmind is a mental health care organization. It is focused on innovative treatments including legal psychedelic medicine. Legal psychedelic medicine includes ketamine and esketamine / Spravato (which are FDA-approved) and other treatments currently in clinical trials including MDMA and psilocybin (among many others). It is headquar... Read More


